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Purpose. To investigate and relate the ultrashort-term and long-term courses of determinants for foreign body reaction as
biocompatibility predictors for meshes in an animal model. Materials and Methods. Three different meshes (TVT, UltraPro, and
PVDF) were implanted in sheep. Native and plasma coated meshes were placed bilaterally: (a) interaperitoneally, (b) as fascia
onlay, and (c) as muscle onlay (fascia sublay). At 5min, 20min, 60min, and 120min meshes were explanted and histochemically
investigated for inflammatory infiltrate, macrophage infiltration, vessel formation, myofibroblast invasion, and connective tissue
accumulation. The results were related to long-term values over 24 months. Results.Macrophage invasion reached highest extents
with up to 60% in short-term and decreased within 24 months to about 30%. Inflammatory infiltrate increased within the first 2
hours, the reached levels and the different extents and ranking among the investigated meshes remained stable during long-term
follow up. For myofibroblasts, connective tissue, and CD31+ cells, no activity was detected during the first 120min. Conclusion.
The local inflammatory reaction is an early and susceptible event after mesh implantation. It cannot be influenced by prior plasma
coating and does not depend on the localisation of implantation.
1. Introduction
Ameshwhen implanted for a particular indication represents
a foreign body which induces a foreign body reaction (FBR).
This reaction is triggered by the initial acute phase reaction
and the subsequent construction of the implant matrix,
mostly conducted by migration of fibroblasts producing
glycosaminoglycans and collagen. The FBR has been his-
tologically described as a foreign body granuloma adjacent
to the mesh fiber and a surrounding collagen capsule that
shields the host from the foreign material. It seems likely that
such a chronic inflammatory process impairs normal wound
healing and tissue regeneration and may result in reduced
functionality and increased side effects when clinically
applied [1]. However, the process of FBR does not necessarily
reduce the proposed mesh function of restoring mechanical
functionality in a particular region of the body. Several
attempts have been conducted to improve biocompatibility
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of meshes and reduce FBR [2–4].The exact FBRmechanisms
and respective time flow in vivo are not entirely understood.
In a previously conducted large animal long-term experiment
over 24 months, applying different meshes and investigating
their biocompatibility course, it could be shown that the
FBR had been already established after 3 months and did
not significantly change over 24 months [5]. Those results
lead to the assumption that FBR is being determined early
in the in vivo course. In addition, in this previous study
the investigated meshes maintained constant positions when
ranking their biocompatibility characteristics and comparing
it to their respective in vitro performances. Aim of this
current study was therefore to investigate the early extent
of macrophage invasion and infiltration of inflammatory
and connective tissue as determinants of FBR immediately
after mesh implantation and to compare those values to the
respective intermediate and long-term performances.
2. Material and Methods
2.1. Animal Studies. We conducted this animal experiment
in accordance with the National Institutes of Health guide-
lines (Guide for the Care and Use of Laboratory Animals).
The experimental protocol was approved by the Animal
Welfare Committee at the University of Szeged, Hungary
(license/permission number V01353/2010). The entire ani-
mal experiment has been divided into a long-term study
investigating biocompatibility over 24 months as previously
published and this current study. The long-term experiment
has been previously described and included 14 animals [5].
For the short-term study, additional three female sheep,
weighing from 20 to 25 kg and at least 6 months old, were
included. Housing and veterinary care were provided at
Szeged University’s farm for experimental animal studies.
We previously selected three meshes characterised as good
(PVDF), intermediate (UltraPro), and poor (TVT, Tension-
free vaginal tape, polypropylene) in vitro and in vivo per-
former according to a recently developed test system and
in vivo long-term evaluation [5, 6]. Surgery was performed
following the protocol as previously described [5]. After a
longitudinal laparotomy, we implanted meshes in 3 different
locations, bilaterally: (a) interaperitoneally, (b) as fascia onlay,
and (c) as muscle onlay (fascia sublay) (Figure 1). The
size of the implanted meshes was 3 × 12 cm. Meshes were
fixed with two sutures at both ends. Mean operation time
for the implantation was 50min. For every native mesh
implant, a respective plasma-coated version was implanted in
equivalent localizations on the contralateral site of the torso.
For this purpose,meshes had been incubatedwith autologous
plasma at least 12 hrs prior to implantation. In the current
study, we selected one sheep per investigated mesh resulting
in 3 animals. Chosen time points for explantation were 5min,
20min, 60min, and 120min. At every explantation time
point, we dissected a piece of about 3 × 4 cm size from the
initially implanted mesh.
2.2. Morphological Studies. A single mesh section (3 × 4 cm)
and adhesive tissue were obtained from each explantedmesh.
Tissue samples were fixed in 10% formalin, then sliced into
0.3 × 1 cm pieces, and embedded in paraffin. Each 10 to 15
sections of 4 𝜇m thickness were stained with haematoxylin
and eosin (H&E), as well as periodic acid Schiff (PAS) plus
diastase and Elastica van Gieson (EvG). All mesh specimens
were studied by lightmicroscopy (LM). LMwas controlled by
immunohistochemistry which was performed on the mate-
rial embedded in paraffin using the avidin-biotin complex
method with diaminobenzidine as a chromogen. The proce-
dure was repeated twice for every sample. Antibodies used
in this study included polyclonal rabbit anti-human CD3,
1 : 50 as pan marker for T-lymphocytes (DAKO, Hamburg,
Germany), polyclonal rabbit anti-human CD138, 1 : 50 as
pan marker for plasma cells (DAKO, Hamburg, Germany),
monoclonal mouse antiporcine CD68, 1 : 50 (DAKO, Ham-
burg, Germany) as panmarker formacrophages, monoclonal
anti-human CD15, 1 : 10 (Becton Dickinson, Heidelberg,
Germany) as marker for polymorphonuclear granulocytes
(PMNs), polyclonal rabbit antiactin protein, 1 : 200 (DAKO,
Hamburg, Germany), and monoclonal anti-CD34 1 : 200
(BIOMOL, Hamburg, Germany) as markers for fibromy-
ocytes as well asmonoclonal porcine CD31, 1 : 10 (DIANOVA,
Hamburg, Germany) as marker for endothelial cells. The
morphometric evaluation consisted of a quantitative cell
analysis of the inflammatory reaction and soft-tissue reaction.
The cells were counted each in 5HE-slides in 10 fields at a
grid of 10 points (100x, area 0.1mm2) and in the interface
(0–300mm, 400x, area 625mm2). Parametersmeasuredwere
the inflammatory infiltrate (𝜇m), connective tissue (𝜇m),
vessels (PV%), macrophages (%), leukocytes (%), polymor-
phonuclear granulocytes (PMNs, %), and fibroblasts (%) as
well as TUNEL, Ki67, and HSP 70 expressing cells (%).
2.3. Statistics. The influence of the clinical data on the
tissue response was tested for significance by performing
an ANOVA with LSD-modification according to Bonferroni
as an established method for comparative experiments in
which only the difference in outcomes is of interest. Statistical
significance was assumed at 𝑃 < 0.05.
3. Results
Overall we did not seeminor normajor complications during
surgery. In addition, no macroscopic differences among the
native and plasma coated meshes immediately after explan-
tation were remarked. As in previous studies, main focus
was set on parameters measured for inflammatory infiltrate,
connective tissue, macrophages (CD68), endothelial cells
as markers for vascularisation, and myofibroblasts when
microscopically investigating the different mesh reactions
after explantation. High extent of connective tissue reaction
and inflammatory reaction was assumed as indicative for
reduced biocompatibility. Figure 2 graphically demonstrates
and relates the short-term and long-term course of 5 impor-
tant markers for early FBR determination.
Within the first two hours after implantation, an early
invasion of macrophages at comparable extent in all meshes
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Figure 1: Intra-operative situs during implantation: (A) intraperitoneal, (B) fascia onlay, (C) muscle onlay. 12 hours prior to implantation
meshes were coated and incubated with autologous plasma. Meshes were implanted bilaterally into the torso to allow intraindividual
comparison of coated versus uncoated meshes per animal.
culminating after 120min was observed.The induced inflam-
matory reaction expressed by the extent of inflammatory
infiltrate revealed the same trend but increased slowly.
Macrophage invasion was detectable after 20min at a rela-
tively high level of about 50% and slightly increased up to
70%. Interestingly, the macrophage invasion was highest in
the PVDF meshes, which in the long-term approach per-
formed best with lowest chronic inflammation. The respec-
tive early inflammatory infiltrate continuously increased
within the first 60min in all investigated meshes. However,
after 120min, this trend inverted in the PVDF meshes. In
contrast, in the TVT and UltraPro, the inflammatory infil-
trate was still increasing towards 120min. Not surprisingly,
no connective tissue was observed after 120min. Additionally
measured endothelial cells representative for vessel integra-
tion and myofibroblasts were all negative during the initial
120min after implantation.
Two markers, representative for early FBR signs, did
show relevant activity within the first two hours after mesh
implantation. Thus for those markers, inflammatory tissue,
and macrophage invasion, a comparison of the coated versus
uncoated version of the respective meshes was possible but
did not show relevant differences.
Each mesh (coated and uncoated) was placed and inves-
tigated in three different positions of the torso (Figure 1).
Neither in the short-term nor in the long-term approach,
we observed differences regarding the reaction of the FBR
determinants on the meshes. In addition, plasma coating did
not have an influence regarding the mesh performance in the
different regions of the body.
4. Discussion
In this animal study we investigated in vivo biocompatibility
predictors for three different meshes by measuring early
and long-term signs of foreign body reaction (FBR) as
macrophage invasion, inflammatory reaction, and connective
tissue determination at the implant site of the meshes. Com-
paring these results to the long-term data in the same species
(sheep), we can show that the process of determination of
FBR is defined early in the course after implantation for
markers of local acute inflammation. In contrast, myofibrob-
last invasion, vascularisation, and connective tissue adhesion
are not relevantly presented in the ultrashort-term course.
The extent of macrophage invasion and inflammatory tissue
does not relevantly increase after 120min compared to the
values for 3 months after explantation or later. A previously
described method to improve biocompatibility performance
of meshes in vivo and in vitro by autologous plasma coating
before implantation did not have an effect on early inflam-
matory events as the respective values for inflammatory
infiltrate andmacrophage invasion did not differ from coated
to native meshes [5–7]. However, markers like connective
tissue organisation, myofibroblast invasion, and endothelial
cells, characteristic for vascularisation, are detectable after 3
months after implantation and show different extents in the
three investigated meshes.
To the best of our knowledge, this current and the
previous study display the longest combined short- and
long-term in vivo approach for investigating biocompatibility
issues on meshes in vivo. In addition, so far, no ultrashort-
term investigations in vivo have been reported as most of
the currently available studies investigated effects on meshes
earliest after 7–21 days [8]. It has been shown that, at 7 days
after implantation of a mesh, an acute inflammatory reaction
occurs, dominated by macrophage invasion [9]. Over time,
this early inflammatory process transforms into a chronic,
at times granulomatous reaction, promoting wound healing
but also forming small granulomas [10]. It is known that the
extent of collagen formation may vary during this process,
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Figure 2: Time course of investigated biocompatibility markers relating ultra short term results to long term results (over 24 months).
whereas a severe inflammatory reaction, with disordered fib-
rin and collagen deposition, is likely to compromise the inte-
gration process and functional outcome. When investigating
prolene and a porcine dermal collagen implant (Pelvicol),
Zheng and colleagues could show a first acute phase reaction
after 48 hours peaking at day 7–14. Our data adds ultrashort-
term information suggesting that this reaction is starting even
earlier in the course, after minutes. Zheng and coworkers
described the acute reaction to diminish and finally reach
negligible levels by 90 days which can be partially supported
in our current study.
Foreign body reactions to alloplastic mesh material are
primarily induced by inflammatory cells like macrophages
and T-lymphocytes [11, 12]. Macrophages have a critical role
in acute inflammation and early vascularisation, as well as
in the subsequent chronic phase of the host response as
they are known to be capable of differentiating towards two
pathways. This M1/M2 polarisation enhances macrophages
leading to an immediate and/or persistent inflammation
or leading to a constructive remodelling and new tissue
generation [13]. However, this polarisation has not been
investigated in the current study. When considering wound
healing, it is known that CD68-positive macrophages reach
their maximum level on second day after injury and slowly
decline afterward [14]. We show that high percentages of
CD68 positive macrophages are detectable on the meshes
after minutes and hours already. Our current data does
not contradict this statement of Engelhardt and coworkers,
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and in contrast, it motivates to more specifically confine
the process of the first acute inflammatory reaction. This
could be of interest when investigating and developing
mesh modification strategies to influence this early acute
reaction. A previously developed plasma coating strategy to
optimize biocompatibility of meshes seems not to influence
this early inflammatory reaction and inflammatory infiltrate
formation but more so to influence mid- and long-term
processes which lead to neovascularization, collagen fibre
organisation. It has been shown that premature type III
collagen is predominantly synthesized in early phases of
wound healing and in the presence of inflammatory cells
[15]. Collagen III is then replaced by highly cross-linked
and stable collagen type I later after implantation. Delayed
wound healing, immature scar development due to persistent
chronic inflammation, may be predicted by a lowered colla-
gen type I/III ratio [16, 17]. A favourable type I/III collagen
ratio is known to improve biocompatibility and can be
positively influenced by preimplantationmeshmodifications,
for instance, gentamicin coating [18]. When considering the
results of the present study, an increase in inflammatory
infiltrate was shown in all three meshes. After 120min
PVDF could be shown to increase considerably slower than
TVT and UltraPro. Although hypothetically, the previously
shown good long-term biocompatibility performance of
PVDF may be triggered by an early decrease of the acute
inflammatory reaction and subsequent modification of the
meshes microenvironment leading to, for example, improved
collagen I/III ratio, we did not observe a direct influence
of the localisation of the implanted mesh in the body in
the short- nor long-term study being reproducible in the
coated and uncoatedmeshes. Although the localisations have
been chosen to cover different structural parts of the body
with different immunologic potential and physical/mechanic
strain, localisation seems not to be of outmost importance for
the biocompatibility performance of a mesh in vivo.
This study has limitations. Only three meshes have been
investigated; thus a higher number of analysedmeshes would
have supported the findings. Meshes have been chosen
based on previously obtained data from in vitro and in vivo
approaches. However, those in vitro studies investigating bio-
compatibility features of randomly selectedmeshes have been
validated in vivo supporting the presented approach. To our
knowledge, this experiment represents the first a combined
ultrashort- and long-term study for biocompatibility features
of native and modified meshes and provides interesting data
for the current understanding of FBR determination and FBR
course in vivo.
5. Conclusion
The local inflammatory reaction is an early and susceptible
event after mesh implantation. It cannot be influenced by
prior plasma coating and does not depend on the localisation
of implantation.
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